A Urinary marker of oxidative stress covaries positively with hostility among midlife community volunteers

Psychosomatic Medicine

Volumn 72, Issue 3, 2010, Pages 273-280

  Carroll, Judith E ^a   Marsland, Anna L ^a   Jenkins, Frank ^c   Baum, Andrew ^d   Muldoon, Matthew F ^a   Manuck, Stephen B ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Department of Psychology   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

8 OHdG; DNA damage; Hostile affect; Hostility; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

ADULT; CARDIOVASCULAR RISK; COMMUNITY SAMPLE; DEMOGRAPHY; FEMALE; HOSTILITY; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; URINARY EXCRETION;

EID: 77951468005     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181d0d72b     Document Type: Review

References (102)

1. Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB Jr. The Cook-Medley hostility scale: item content and ability to predict survival. Psychosom Med 1989;51:46-57.
2. Buss AH. The Psychology of Aggression. New York: Wiley; 1961.
3. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ. A meta-analytic review of research on hostility and physical health. Psychol Bull 1996;119:322-348
4. Kuper H, Marmot M, Hemingway H. Systematic review of prospective cohort studies of psychosocial factors in the etiology and prognosis of coronary heart disease. Semin Vasc Med 2002;2:267-314.
5. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, Oldenburg BF, Peach HG, Ruth D, Tennant CC, Tonkin AM. "Stress" and coronary heart disease: psychosocial risk factors. Med J Aust 2003;178:272-276
6. Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular disease. Annu Rev Public Health 2005;26:469-500.
7. Krantz DS, McCeney MK. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Annu Rev Psychol 2002;53:341-369
8. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217
9. Myrtek M. Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility. Int J Cardiol 2001;79:245-251
10. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004;101:17312-17315
11. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy- 2'deoxyguanosine in clinical depression. Psychosom Med 2006;68:1-7.
12. Hapuarachchi JR, Chalmers AH, Winefield AH, Blake-Mortimer JS. Changes in clinically relevant metabolites with psychological stress parameters. Behav Med 2003;29:52-59
13. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, Chris-tophe A. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 2000;58:241-246
14. Sies H. What is oxidative stress? In: Keaney JF, editor. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers; 1999.
15. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90: 7915-7922
16. Chung HY, Jung KJ, Yu BP. Molecular inflammation as an underlying mechanism of aging: the anti-inflammatory action of calorie restriction. In: Surh Y, Packer L, editors. Oxidative Stress, Inflammation, and Health. Boca Raton, FL: Taylor & Francis Group; 2005.
17. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239-267
18. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9.
19. Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke S, Haenen G, Hoberg A, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Mol Aspects Med 2002;23:101-208.
20. Andreassi MG, Botto N. Genetic instability, DNA damage and atherosclerosis. Cell Cycle 2003;3:224-227
21. Gordon MB, Libby P. Atherosclerosis. In: Sun B, editor. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Baltimore: Lippincott Williams & Wilkins; 2002.
22. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part 1: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-1916
23. Keaney JF. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publisher; 1999.
24. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996;74:297-312.
25. Mahmoudi M, Mercer J, Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc Res 2006;71:259-268
26. Noguera A, Battle S, Miralles C, Iglesias J, Busquets X, MacNee W, Agusti AG. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001;56:432-437
27. Steptoe A, Brydon L. Psychoneuroimmunology and coronary heart disease. In: Vedhara K, Irwin M, editors. Human Psychoneuroimmu-nology. New York: Oxford University Press; 2005.
28. Tsimikas S, Witztum JL. The oxidative modification hypothesis of atherogenesis. In: Keaney JF, editor. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers; 1999.
29. Andreassi MG. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat Res 2002;543:67-86.
30. Botto N, Masetti S, Manfredi S, Petrzozzi L, Vassale C, Biagini A, Andreassi MG. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002;13:269-274
31. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005;570:197-203.
32. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;106:927-932
33. Gur M, Yilmaz R, Demirbag R, Yildiz A, Kocyigit A, Celik H, Cayli M, Polat M, Bas MM. Lymphocyte DNA damage is associated with increased aortic intima-media thickness. Mutat Res 2007;617:111-118
34. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brumer J, Gutzki FM, Chem I, Berger J, Frolich JC, Boger RH. Urinary 8-iso-prostaglandin F2-alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004;109:843-848
35. Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommer-ville K, Leake D, Taub N. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995;112:77-84.
36. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Sa-lonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992; 339:883-888
37. Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 2006;52:446-452
38. Sivonova M, Zitnanova I, Hlincikova L, Skodacek I, Trebaticka J, Durackova ZK. Oxidative stress in university students during examinations. Stress 2004;7:183-188
39. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003;8:365-370
40. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psycho-pharmacol 2004;19:89-95.
41. Adachi S, Kawamura K, Takemoto K. Oxidative damage of nuclear DNA in liver of rats exposed to psychological stress. Cancer Res 1993;53:4153-4155
42. Fischman HK, Pero RW, Kelly DD. Psychogenic stress induces chromosomal and DNA damage. Int J Neurosci 1996;84:219-227
43. Flint MS, Carroll JE, Jenkins FJ, Chambers, WH, Han ML, Baum A. Genomic profiling of restraint stress-induced alterations in mouse T lymphocytes. J Neuroimmunol 2005;167:34-44.
44. Barja de Quiroga G, Lopez-Torres M, Perez-Campo R, Abelenda M, Paz Nava M, Puerta ML. Effect of cold acclimation on GSH, antioxidant enzymes and lipid peroxidation in brown adipose tissue. Biochem J 1991;277:289-292
45. Ceremuzynski L, Barcikowski B, Lewicki Z, Wutzen J, Gordon-Majszak W, Famulski KS, et al. Stress-induced injury of pig myocardium is accompanied by increased lipid peroxidation and depletion of mitochondrial ATP. Exp Pathol 1991;43:213-220
46. Das D, Bandyopadhyay D, Bhattacharjee M, Banerjee RK. Hydroxyl radical is the major causative factor in stress-induced gastric ulceration. Free Rad Bio Med 1997;23:8-18.
47. Davydov VV, Shvets VN. Lipid peroxidation in the heart of adult and old rats during immobilization stress. Exp Gerontol 2001;36:1155-1160
48. Ohira T, Hozawa A, Iribarren C, Daviglus ML, Matthews KA, Gross MD, Jacobs DR. Longitudinal associations of serum carotenoids and tocopherols with hostility: the CARDIA study. Am J Epidemiol 2008; 167:42-50.
49. Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res 2001;92:367-376
50. Sherwood A, Hughes JW, Kuhn C, Hinderliter AL. Hostility is related to blunted/3-adrenergic receptor responsiveness among middle-aged women. Psychosom Med 2004;66:507-513
51. Suarez EC, Kuhn CM, Schanberg SM, Williams RB Jr, Zimmermann EA. Neuroendocrine, cardiovascular, and emotional responses of hostile men: the role of interpersonal challenge. Psychosom Med 1998;60: 78-88.
52. Barefoot JC, Larsen S, von der Lieth L, Schroll M. Hostility, incidence of acute myocardial infarction, and mortality in a sample of older Danish men and women. Am J Epidemiol 1995;142:477-484
53. Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scores for the MMPI. J Appl Psychol 1954;38:414-418
54. Contrada RJ, Jussim L. What does the Cook-Medley hostility scale measure? In search of an adequate measurement model. J Appl Soc Psychol 1992;22:615-627
55. Boyle SH, Williams RB, Mark DB, Brummett BH, Siegler IC, Helms MJ, Barefoot JC. Hostility as a predictor of survival in patients with coronary artery disease. Psychosom Med 2004;66:629-632
56. Boyle SH, Jackson WG, Suarez EC. Hostility, anger, and depression predict increases in C3 over a 10-year period. Brain Behav Immun 2007;21:816-823
57. Iribarren C, Sidney S, Bild DE, Liu K, Markovitz JH, Rosenman JM, Matthews K. Association of hostility with coronary artery calcification in young adults: the CARDIA study. Coronary artery risk development in young adults. JAMA 2000;283:2546-2551
58. Marsland AL, Prather AA, Petersen KL, Cohen S, Manuck SB. Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun 2008;22:753-761
59. Sloan RP, Bagiella E, Shapiro PA, Kuhl JP, Chernikhova D, Berg J, Myers MM. Hostility, gender, and cardiac autonomic control. Psychosom Med 2001;63:434-440
60. Cook MS, Lunec J, Evans MD. Progress in the analysis of urinary oxidative DNA damage. Free Radic Biol Med 2002;33:1601-1614 (Pubitemid 35462001)
61. Scherwitz LW, Perkins LL, Chesney MA, Hughes GH, Sidney S, Manolio TA. Hostility and health behaviors in young adults - the CARDIA study. Am J Epidemiol 1992;136:136-145
62. Siegler IC. Hostility and risk: demographic and lifestyle variables. In: Siegman AW, Smith TW, editors. Anger, Hostility, and the Heart. Hillsdale, NJ: Erlbaum; 1994.
63. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-1737
64. Negishi H, Ikeda K, Kuga S, Noguchi T, Kanda T, Njelekela M, Liu L, Miki T, Nara Y, Sato T, Mashala Y, Mtabaji J, Yamori Y. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J Hypertens 2001;19:529-533
65. Leeuwenburgh C, Heinecke JW. Oxidative stress and antioxidants in exercise. Curr Med Chem 2001;8:829-838
66. Mizoue T, Tokunaga S, Kasai H, Kawai K, Sato M, Kubo T. Body mass index and oxidative DNA damage: a longitudinal study. Cancer Sci 2007;98:1254-1258
67. Pilger A, Ivancsits S, Germadnik D, Rudiger HW. Urinary excretion of 8-hydroxy-2'-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 2002;778:393-401.
68. Hofer T, Karlsson HL, Moller L. DNA oxidative damage and strand breaks in young healthy individuals: a gender difference and the role of life style factors. Free Radic Res 2006;40:707-714
69. 2-isoprostane formation: population, age, gender and smoking habits in humans. Free Radic Res 2009;43:1-7.
70. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002;156:274-285
71. Giovannelli L, Saieva C, Masala G, Testa G, Salvini S, Pitozzi V, Riboli E, Dolara P, Palli D. Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis 2002;23:1483-1489
72. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-2247
73. Proteggente AR, England TG, Rehman A, Rice-Evans CA, Halliwell B. Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals. Free Radic Res 2002;36:157-162
74. Tarwadi K, Agte V. Linkages of antioxidant, micronutrient, and socioeconomic status with the degree of oxidative stress and lens opacity in Indian cataract patients. Nutrition 2004;20:261-267
75. Taylor AW, Bruno RS, Traber MG. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology. Lipids 2008;43:925-936
76. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
77. Kaplan GA, Keil JE. Special report: socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88: 1973-1998
78. Paffenberger RS, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-175
79. Schurmeyer TH, Wickings EJ. Principles of Endocrinology. In: Sched-lowski M, Tewes U, editors. Psychoneuroimmunology: An Interdisciplinary Introduction. New York: Kluwer Academic/Plenum Publishers; 1999.
80. Pope MK, Smith TW. Cortisol excretion in high and low cynically hostile men. Psychosom Med 1991;53:386-392
81. Okamoto T, Adachi K, Muraishi A, Seki Y, Hidaka T, Toshima H. Induction of DNA breaks in cardiac myoblast cells by norepinephrine. Biochem Mol Biol Int 1996;38:821-827
82. Flint MS, Baum A, Chambers WH, Jenkins FJ. Induction of DNA damage, alterations of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology 2007;32:470-479
83. Zhang J, Niaura R, Dyer JR, Shen B-J, Todaro JF, McCaffery JM, Spiro A, Ward KD. Hostility and urine norepinephrine interact to predict insulin resistance: the VA normative aging study. Psychosom Med 2006;68:718-726
84. Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 2001;53:487-525.
85. Dong E, Yatani A, Mohan A, Liang CS. Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol 1999;384:17-24.
86. Black PH, Garbutt LD. Stress, inflammation, and cardiovascular disease. J Psychosom Res 2002;52:1-23.
87. Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiological mechanisms. Psychosom Med 1991;53: 643-668
88. Meisenber G, Simmons WH. Principles of Medical Biochemistry. Philadelphia: Mosby; 2006.
89. Rushmer RF. Structure and Function of the Cardiovascular System. In: Schneiderman N, Weiss SM, Kaufmann PG, editors. Handbook of Research Methods in Cardiovascular Behavioral Medicine. New York: Plenum Press; 1989.
90. Heinecke JW. Sources of vascular oxidative stress. In: Keaney JF, editor. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers; 1999.
91. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal 2006;8:572-581
92. Tsimikas S, Witztum JL. The oxidative modification hypothesis of atherogenesis. In: Keaney JF, editor. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers; 1999.
93. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease. Circulation 2003;107:499-511.
94. Kotur-Steveuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z, Zunic G. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007;40:181-187
95. Dohi Y, Takase H, Sato K, Ueda R. Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Int J Cardiol 2007;115:63-66
96. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, Harrison DG, Quyyumji AA, Vaccarino V. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 2005;178: 115-121
97. Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008;44:1203-1208
98. Siegler IC, Costa PT, Brummett BH, Helms MJ, Barefoot JC, Williams RB, Dahlstrom WG, Kaplan BH, Vitaliano PP, Nichaman MZ, Day RS, Rimer BK. Patterns of Change in Hostility from College to Midlife in the UNC Alumni Heart Study Predict High-Risk Status. Psychosom Med 2003;65:738-745
99. Cherubini A, Vigna GB, Zuliani G, Ruggiero C, Senin U, Fellin R. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr Pharm Des 2005;11:2017-2032
100. Freese R. Markers of oxidative DNA damage in human interventions with fruit and berries. Nutr Cancer 2006;54:143-147
101. Peoples MC, Karnes HT. Recent developments in analytical methodology for 8-hydroxy-2'-deoxyguanosine and related compounds. J Chro-matogr B Analyt Technol Biomed Life Sci 2005;827:5-15.
102. Miwa M, Matsumaru H, Akimoto Y, Naito S, Ochi H. Quantitative determination of urinary 8-hydroxy-2'-deoxyguanosine level in healthy Japanese volunteers. Biofactors 2004;22:249-253